GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentat
Recalled October 15, 2025 · FDA recall D-0065-2026 · GenoGenix
Hazard
Lack of Assurance of Sterility · FDA Class II
Sold at
US Nationwide.
Description
Lack of Assurance of Sterility
Product
NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health
Manufacturer(s)
GenoGenix LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →